Search clinical trials for: mometasone furoate dry powder inhaler

Total 410 results

Organon and Co

Completed

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)

Asthma
Organon and Co

Completed

A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)

Asthma
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers (PIFECO)

Pulmonary Disease, Chronic Obstructive | Asthma

United Kingdom, Finland
Esfam Biotech Pty Ltd

Not yet recruiting

A Dose Escalation Phase 1 Study Evaluating the Safety and Pharmacokinetics of an Inhaled COVID-19 Inhibitor Delcetravir in Healthy Subjects

COVID-19
Organon and Co

Withdrawn

Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)

Asthma
Vectura Limited
UCB Pharma

Completed

An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma

Asthma

United Kingdom
Jeffrey Glassberg
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2 (IMPROVE2)

Sickle Cell Disease

United States
GB002, Inc.

Not yet recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Pulmonary Arterial Hypertension

United States
GB002, Inc.

Recruiting

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Pulmonary Arterial Hypertension

United States, Spain, Israel, Korea, Republic of, Netherlands, France, Singapore, United Kingdom, Lithuania, Australia, Latvia, Argentina, Portugal, Greece, Czechia, Puerto Rico, Belgium, Italy, Poland, Romania, Serbia, Austria, Chile, Denma... and more
GB002, Inc., a wholly owned subsidiary of Gossamer...

Recruiting

Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States, Australia, Spain, Czechia, France, Germany, United Kingdom, Belgium
GB002, Inc., a wholly owned subsidiary of Gossamer...

Completed

Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States, United Kingdom
Organon and Co

Completed

A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)

Asthma
Organon and Co

Terminated

Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)

Asthma
GB002, Inc., a wholly owned subsidiary of Gossamer...
Worldwide Clinical Trials; Pulmokine Inc.

Completed

Phase 1A Safety Trial of Inhaled PK10571 (GB002)

Safety Issues

United States
GB002, Inc., a wholly owned subsidiary of Gossamer...

Completed

GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

Pulmonary Artery Hypertension

United States, Spain, Australia, Germany, Serbia, Czechia, Belgium, Canada, Austria, France, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices

Asthma

Germany, Netherlands, United Kingdom
University of Pittsburgh
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Stress and Treatment Response in Puerto Rican Children With Asthma (STAR)

Asthma in Children

United States, Puerto Rico
Teva Pharmaceuticals USA

Completed

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Seasonal Allergic Rhinitis
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions

Healthy
Eurofarma Laboratorios S.A.

Completed

A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)

Mild to Moderate Persistent Allergic Rhinitis

Brazil
Organon and Co

Completed

Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)

Asthma
Massachusetts General Hospital
Merck Sharp & Dohme LLC; Massachusetts Eye and Ear Infirmary

Terminated

An Open-label Study to Identify Molecular Markers of Steroid Resistance (MERK2)

Nasal Polyps

United States
Receptor Life Sciences

Withdrawn

Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)

Social Anxiety Disorder

United States
Montefiore Medical Center

Withdrawn

Topical Steroids & Bacterial Decolonization for Radiation Dermatitis

Radiation Dermatitis

United States
University of Florida
GlaxoSmithKline; Food and Drug Administration (FDA)

Completed

Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays

Hypersensitivity

United States
GlaxoSmithKline

Completed

Long Term Safety Of GW685698X Via Nasal Biopsy

Rhinitis, Allergic, Perennial

Netherlands, Belgium
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma

Asthma

Germany, Slovakia, Bulgaria, Canada, Poland, Korea, Republic of, Netherlands, Japan
Novartis Pharmaceuticals

Completed

Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

Mild Asthma

Germany, India, Korea, Republic of, Poland, South Africa, Estonia, Italy, Russian Federation, Thailand, Latvia, Lithuania, Colombia, Hungary, Peru, Philippines, Slovakia, Bulgaria, Vietnam, Japan, Malaysia, Chile, Sweden
James J. Peters Veterans Affairs Medical Center
Kessler Institute for Rehabilitation

Unknown

Acute and Chronic Effects of Inhaled Steroids on Pulmonary Function in Persons With Spinal Cord Injury

Spinal Cord Injury

United States
Intersect ENT

Completed

Safety and Performance of the Steroid-Releasing S8 Sinus Implant (S8PK)

Chronic Sinusitis

United States
Organon and Co

Completed

Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)

Rhinitis, Allergic, Perennial
Sandoz

Completed

A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Rhinitis, Allergic, Seasonal

United States
Organon and Co

Completed

Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)

Rhinitis, Allergic
JHSPH Center for Clinical Trials
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Study of Asthma and Nasal Steroids (STAN)

Asthma | Sinusitis | Rhinitis

United States
Organon and Co

Completed

A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)

Rhinitis, Allergic, Perennial
Intersect ENT

Completed

S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps (RESOLVE_II)

Chronic Sinusitis | Nasal Polyposis

United States
Organon and Co

Completed

A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177)

Asthma
Organon and Co

Completed

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)

Seasonal Allergic Rhinitis
Lyra Therapeutics

Completed

480 Biomedical Sinus Drug Depot

Chronic Sinusitis

New Zealand, Australia
Children's & Women's Health Centre of British Columbia

Withdrawn

Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy (Nasonex OSA)

Obstructive Sleep Apnea (Mild, Moderate, Severe) as Per Polysomnography

Canada
Novartis
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma

Asthma

France
Alkahest, Inc.

Terminated

A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid

Pemphigoid, Bullous

Germany
Memorial Sloan Kettering Cancer Center

Completed

Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation

Invasive Breast Cancer

United States
PH&T S.p.A.

Unknown

Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays (PHT-01-12)

Nasal Obstruction | Sneezing | Itching

Argentina
California Allergy and Asthma Medical Group, Inc.

Completed

Onset and Duration of Mometasone by Oscillometry and Spirometry

Asthma

United States
Organon and Co

Completed

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)

Seasonal Allergic Rhinitis
Benha University

Completed

Corticosteroid Nasal Spray in COVID-19 Anosmia

Covid19 | Anosmia

Egypt
Schering-Plough

Terminated

Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)

Perennial Allergic Rhinitis
Respira Therapeutics, Inc.

Completed

A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Australia
Medisol Development Kft.
University of Debrecen; St. Borbala Hospital; Pest County Pulmonology Hospital; Medical Centre Hungarian Defence Forces and other collaborators

Active, not recruiting

Breathing Parameter Measurements for Lung Deposition Simulation (CHOICE)

Asthma | COPD

Hungary

3

Subscribe